NCT07128680 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT07128680
Title	Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer
Recruitment	Not yet recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	City of Hope Medical Center
Indications	renal cell carcinoma
Therapies	EXL01 + Ipilimumab + Nivolumab Ipilimumab + Nivolumab
Age Groups:	adult \| senior
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
City of Hope Medical Center		Duarte	California	91010	United States	Details
City of Hope Medical Center		Irvine	California	92618	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT07128680Clinical Trial Detail